Lv11
4 积分 2023-04-10 加入
Comparative requirements for exploratory clinical trials — eIND, eCTA and microdosing
3小时前
已完结
Phase 0 trials
6小时前
已完结
Genetically modified organisms in Korea: state of affairs, policy, and regulation
7天前
已完结
UK NHS to enrol thousands in trials of personalised mRNA cancer vaccines
9天前
已完结
Regulatory perspective for quality evaluation of lipid nanoparticle-based mRNA vaccines in China
18天前
已完结
Removing Immunogenic Double-stranded RNA Impurities Post In Vitro Transcription Synthesis for mRNA Therapeutics Production: A Review of Chromatography Strategies
18天前
已完结
Regulatory Considerations for Producing mRNA Vaccines for Clinical Trials
18天前
已完结
Gene therapy in China: From a clinician’s perspective
25天前
已完结
An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies
26天前
已完结
GMP manufacturing of cell and gene therapy products: Challenges, opportunities, and pathways forward
26天前
已完结
皖公网安备34019202002308
